FDA Issues Discussion Paper on Generative AI Medical Devices

The FDA's digital health center has released a discussion paper on regulatory considerations for generative AI medical devices, covering risk assessment, premarket evaluation, and postmarket management, and is soliciting stakeholder feedback.

2026-08-25 ~ 2026-08-26 · 2 related posts

• FDA issues discussion paper on regulation of generative AI-enabled medical devices — emmanuelvivier · 2026-08-25

1 near-duplicate retellings: luisdans